Acute Malaria

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Acute Malaria trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT07345286

Clinical Aspects, Management and Surveillance of Febrile Illnesses in DRC

The epidemiology and outcome of febrile illnesses in the Democratic Republic of Congo (DRC) is poorly documented. The FIKI² study, a prospective observational s…

Democratic Republic of the Congo500 participantsStarted 2025-01-20

All recent trials (69 shown)

CompletedPhase 2

NCT04546633

Efficacy, Safety and Tolerability of KAF156 in Combination With Lumefantrine Solid Dispersion Formulation (LUM-SDF) in P…

This study aimed to determine the efficacy, safety and tolerability of the investigational drug KAF156 in combination with a solid dispersion formulation of lum…

Burkina Faso, Côte d’Ivoire295 participantsStarted 2021-02-16

Treatment: KAF156, LUM-SDF

CompletedNot Applicable

NCT04529434

Star Homes Project 2

Malaria, pneumonia and diarrhoea causes a lot of illness in children in Tanzania and the study want to find better ways of protecting people against these disea…

Tanzania1,183 participantsStarted 2022-01-04

Treatment: Star Homes, Traditional African houses

Acute Malaria

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Clinical Aspects, Management and Surveillance of Febrile Illnesses in DRC

All recent trials (69 shown)

Efficacy, Safety and Tolerability of KAF156 in Combination With Lumefantrine Solid Dispersion Formulation (LUM-SDF) in P…

Star Homes Project 2

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Clinical Aspects, Management and Surveillance of Febrile Illnesses in DRC

All recent trials (69 shown)

Efficacy, Safety and Tolerability of KAF156 in Combination With Lumefantrine Solid Dispersion Formulation (LUM-SDF) in P…

Star Homes Project 2

Leveraging the Seasonal Malaria Chemoprevention Platform to Address Malaria and Malnutrition

Pharmacokinetics, Safety, Tolerability and Efficacy of a New Artemether-lumefantrine Dispersible Tablet in Infants and N…

Phase IIa Proof of Concept Study of M5717-Pyronaridine in Adults and Adolescents With Acute Uncomplicated Plasmodium Fal…

Safety and Efficacy of Different Regimens of Primaquine on Vivax Malaria Treatment in G6PD Deficient Patients

Enhancing Pediatric Acute Care Through Adaptive E-Learning and In-Person Skills Practice in Tanzania

Efficacy of SJ733 in Adults With Uncomplicated Plasmodium Falciparum or Vivax Malaria

Effect of Paracetamol on Kidney Function in Severe Malaria

Cluster Randomised Trial of Malaria RDTs Used by CHWs in Afghanistan

Pyronaridine and Artesunate (3:1) in Children With Acute Uncomplicated Plasmodium Falciparum Malaria

Efficacy and Safety of Pyronaridine-Artesunate Versus Artemether-Lumefantrine

Efficacy and Safety of KAF156 in Combination With LUM-SDF in Adults and Children With Uncomplicated Plasmodium Falciparu…

Baromètre Santé Adulte 2021-2022

Safety and Efficacy of Pyronaridine Artesunate Vs Chloroquine in Children and Adult Patients With Acute Vivax Malaria

MMV390048 POC in Patients With P. Vivax and P. Falciparum Malaria

Pyronaridine Artesunate 3:1 Granule Formulation vs. Coartem© Crushed Tablets in P. Falciparum Malaria Pediatric Patients

Liberia National Community Health Assistant (NCHA) Program and Under-five Mortality

Pyronaridine - Artesunate (3:1) Versus Mefloquine Plus Artesunate in Plasmodium Falciparum Malaria Patients

Phase II Dose-ranging Study of Pyronaridine/Artesunate in Adults Patients With Plasmodium Falciparum Malaria